Skip to main content

Market Overview

3D System Shares Under Pressure Despite Bullish Comments From BB&T

Share:

Shares of 3D Systems are down another 5.3 percent to $52.41 in the face of some bullish comments from BB&T.

Analyst Holden Lewis is impressed by the company's financials. Management “continues to expect 30%+ organic growth and ~$1B in sales in 2015.” Lewis is forecasting $933.4 million, which is higher than the consensus estimates of $917.8 million.

Margins should also continue to rise “as faster growth from materials and software as well as margin gains from its service bureau assets offset mix shifts elsewhere,” said the analyst.

While the financial details of the Medical Modeling acquisition “are unlikely to be disclosed before the Q1'14 report,” the deal makes sense to Lewis. “14% of 3D Systems' sales are healthcare, but mostly outside-the-body applications” such as orthopedics, dental, and hearing, but the acquisition allows 3D to go inside the body “with software for imaging/modeling and printing capabilities for guides/implants.”

Lewis has a Buy rating on the stock.

Latest Ratings for DDD

DateFirmActionFromTo
Nov 2021Lake StreetInitiates Coverage OnBuy
Mar 2021Loop CapitalUpgradesSellHold
Jan 2021BerenbergDowngradesBuyHold

View More Analyst Ratings for DDD

View the Latest Analyst Ratings

 

Related Articles (DDD)

View Comments and Join the Discussion!

Posted-In: BB&T Holden LewisAnalyst Color Analyst Ratings

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com